Aspyra, Inc. (AMEX:APY) entered into a distributor agreement with Merry X-Ray Corporation (MXR)/SourceOne Healthcare Technologies allowing MXR to distribute Aspyra's AccessNET PACS and AccessMED Specialty PACS solutions nationwide. MXR is the largest nationwide distributor in the X-Ray and Imaging industry. SourceOne Healthcare Technologies is a subsidiary of MXR, located in Mentor, OH.
The distributor agreement with Aspyra enables MXR to be a single-point of contact to the imaging and orthopedic customer. "Providing a PACS solution to our customers, such as Aspyra's PACS, allows us to offer a comprehensive portfolio of electronic imaging solutions to our customers," comments Jeff Root, Director of Imaging for MXR. He adds, "We are excited about the opportunity to provide Aspyra products and services to our family of customers."
"Aspyra's PACS solutions are designed to enhance the imaging workflow, boost efficiency and reduce costs of a hospital or clinic imaging department or orthopedic group practice," states Bill Culton, Aspyra's Diagnostic Solutions Product Manager. He adds, "Combining PACS with solutions such as CR and DR helps the facility to move towards a filmless environment."
The 3-year national distributor agreement became effective July 1, 2006.
About Merry X-Ray
For almost half a century, Merry X-Ray (MXR) Corporation has met the challenges of keeping pace with the rapidly changing technology within the medical imaging profession. Most dramatic of these changes has been the migration from analog imaging to today's trend of digital medical imaging. In 1998, MXR created its Digital Imaging Division to respond to these current needs. MXR's electronic product portfolio is rich with vendor partners and solutions to meet any digital imaging need -- from basic teleradiology to enterprise-wide PACS. MXR represents over 8,000 products and has thirty-eight branches nationwide. MXR is the largest nationwide distributor in the X-Ray and Imaging industry. For more information about Merry X-Ray Corporation, please visit www.merryxray.com.
Aspyra is a global provider of clinical and diagnostic information solutions for the healthcare industry. We have over 35 years of industry experience, specializing in enterprise-wide systems for hospitals, multi-specialty clinics, clinical laboratories, imaging departments and centers, orthopedic environments and pharmacies. Our highly scalable products may be installed as standalone or integrated to provide a single-vendor solution.
For more information on Aspyra, its products and services, visit www.aspyra.com.
This press release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to anticipated revenues, expenses, earnings, operating cash flows, the outlook for Aspyra's markets and the demand for its products. Forward-looking statements are not guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statements. Such statements are based upon, among other things, assumptions made by, and information currently available to, management, including management's own knowledge and assessment of the Company's industry and competition. Factors that could cause Aspyra's actual results to differ materially from these forward-looking statements include among others: whether the combined company will realize the potential benefits of the merger; the competitive environment; unexpected technical and marketing difficulties inherent in major product development efforts; the potential need for changes in our long-term strategy in response to future developments; future advances in clinical information technology and procedures, as well as potential changes in government regulations and healthcare policies; and rapid technological change in the microelectronics and software industries. The Company refers interested persons to its most recent Annual Report on Form 10-KSB and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The Company assumes no duty to update its forward-looking statements.